A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.
Shaoji Cheng, Cornelius J Clancy, Katherine T Nguyen, William Clapp, M Hong Nguyen
Index: Antimicrob. Agents Chemother. 51 , 1855-8, (2007)
Full Text: HTML
Abstract
We showed that a Candida albicans petite mutant in which oxidative phosphorylation is uncoupled was eightfold more resistant to fluconazole and voriconazole than SC5314 but equally susceptible to ketoconazole, itraconazole, and amphotericin B. Strain P5 significantly overexpressed MDR1, which likely accounts for the decreased drug susceptibility.
Related Compounds
Related Articles:
2014-01-01
[MBio 5(5) , e01921-14, (2014)]
2015-03-01
[J. Virol. 89(5) , 2698-709, (2015)]
2014-07-01
[Infect. Immun. 82(7) , 3033-44, (2014)]
2014-11-01
[J. Immunol. 193(9) , 4527-36, (2014)]
2015-03-14
[Br. J. Nutr. 113(5) , 770-82, (2015)]